Antimicrobial resistance in bacterial meningitis caused by Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae (2010–24): a systematic review and meta-analysis
The Lancet Microbe · 2026-02 · 7 (2) · 101238
DOI: 10.1016/j.lanmic.2025.101238 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Lancet Microbe, 2026-02. Verfasst von Gilbert Lazarus und 17 weiteren Autor:innen. Beteiligte Einrichtung: Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Neisseria meningitidis, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization, JG CDC HHS, Canada Research Chairs.
Abstract (Originalsprache)
BACKGROUND: There are fragmented data on the patterns of antimicrobial resistance in the main bacterial pathogens causing meningitis, especially in low-income and middle-income countries (LMICs) where the disease burden is highest. This review aimed to estimate meningitis-specific prevalence of antimicrobial resistance and time trends, globally and for each of the WHO regions, for the main antimicrobials used to treat or prevent meningitis. METHODS: In this systematic review and meta-analysis, we systematically searched Embase, Global Health Database, and MEDLINE for original, peer-reviewed articles in any language, published between Jan 1, 2010, and May 16, 2024, describing people diagnosed with a microbiologically confirmed meningitis caused by Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae, with antimicrobial susceptibility testing results. We excluded reports that did not describe specimen type, sampling period, geographical setting, denominators, or proportions for single-agent and class resistance. We used multilevel random-effect meta-analysis on summary data to estimate the prevalence and time trends of antimicrobial resistance for relevant pathogen-antimicrobial combinations in each WHO region and globally. To assess article quality, we adopted the Microbiology Investigation Criteria for Reporting Objectively (MICRO) checklist. This review was registered with PROSPERO (CRD42019155379). FINDINGS: The search yielded 1503 studies. After the removal of 606 duplicates, 665 from title and abstract screening, and 140 from full-text screening, 92 reports were eligible for inclusion. A further four were removed due to duplicate datasets. We included 88 reports and extracted data on 16 441 clinical isolates from 37 countries across all WHO regions, mostly LMICs. For S pneumoniae (81 reports, 13 295 isolates), prevalence of antimicrobial resistance was highest in the Western Pacific and Eastern Mediterranean regions, ranging across WHO regions from 14·7% (95% CI 4·5-29·5) to 58·0% (34·9-79·5) for benzylpenicillin (27·4% [19·0-36·6] globally), and from 3·8% (0·0-13·7) to 20·6% (2·2-50·8) for third-generation cephalosporins (3GCs; 8·8% [4·3-14·6] globally). Benzylpenicillin resistance in S pneumoniae meningitis increased over time in LMICs, whereas benzylpenicillin and 3GC resistance decreased over time in high-income countries. For N meningitidis (11 reports, 3001 isolates), prevalence of antimicrobial resistance was highest in the African region, ranging across WHO regions from 9·4% (7·2-11·8) to 44·9% (0·0-100·0) for benzylpenicillin (24·7% [5·3-52·3] globally, increasing over time); from 0·0% (0·0-0·1) to 17·0% (0·0-100·0) for 3GCs (4·6% [0·0-19·4] globally); and from 0·0% (0·0-0·2) to 17·1% (0·0-100·0) for ciprofloxacin (3·7% [0·0-25·9] globally). Among H influenzae isolates (five reports, 145 isolates), 51·2% (0·0-100·0) were ampicillin resistant and 8·4% (0·1-28·4) were 3GC resistant globally; data were insufficient for WHO regions. None of the included reports described all 13 MICRO mandatory items, with a median of four (range one to six) items missing. INTERPRETATION: Treatment of bacterial meningitis is challenged by a rise of antimicrobial-resistant pathogens, particularly affecting patients in LMICs where access to effective treatment might be limited. Our findings call for the strengthening of national antimicrobial resistance surveillance systems to better tailor treatment guidelines and public health interventions. FUNDING: Fleming Fund, US Centers for Disease Control and Prevention (CDC), and WHO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada; AMR-One Health Consortium, Calgary, AB, Canada.
- Department of Antimicrobial Resistance, WHO, Geneva, Switzerland. Electronic address: deanan@who.int.
- AMR-One Health Consortium, Calgary, AB, Canada; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Alberta Health Services, Calgary, AB, Canada.
- Department of Pandemic and Epidemic Management, WHO, Geneva, Switzerland.
- Department of Antimicrobial Resistance, WHO, Geneva, Switzerland; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Julius Center for Health Sciences and…
Förderung
- World Health Organization
- JG CDC HHS
- Canada Research Chairs
- Wellcome Trust
- Centers for Disease Control and Prevention
Zitieren
APA
Lazarus, G., Caddey, B., Dean, A., Febrina, F., Wangsaputra, V. K., Radiani, S. P., Xiong, Y., Conly, J. M., Barkema, H. W., Pezzoli, L., van Kleef, E., Tosas Auguet, O., Turner, P., Kothari, K. U., Bertagnolio, S., Nobrega, D. B., Hamers, R. L., & WHO AMR Prevalence Systematic Review Collaborators (2026). Antimicrobial resistance in bacterial meningitis caused by Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae (2010–24): a systematic review and meta-analysis. The Lancet Microbe, 7(2), 101238. https://doi.org/10.1016/j.lanmic.2025.101238
Vancouver
Lazarus G, Caddey B, Dean A, Febrina F, Wangsaputra VK, Radiani SP, et al. Antimicrobial resistance in bacterial meningitis caused by Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae (2010–24): a systematic review and meta-analysis. The Lancet Microbe. 2026;7(2):101238. doi:10.1016/j.lanmic.2025.101238
BibTeX
@article{Lazarus2026,
author = {Lazarus, Gilbert and Caddey, Benjamin and Dean, Anna and Febrina, Florentina and Wangsaputra, Vincent Kharisma and Radiani, Shafira Permata and Xiong, Yindi and Conly, John M and Barkema, Herman W and Pezzoli, Lorenzo and van Kleef, Esther and Tosas Auguet, Olga and Turner, Paul and Kothari, Kavita U and Bertagnolio, Silvia and Nobrega, Diego B and Hamers, Raph L and WHO AMR Prevalence Systematic Review Collaborators, WHO AMR Prevalence Systematic Review Collaborators},
title = {Antimicrobial resistance in bacterial meningitis caused by Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae (2010–24): a systematic review and meta-analysis},
journal = {The Lancet Microbe},
year = {2026},
volume = {7},
number = {2},
pages = {101238},
doi = {10.1016/j.lanmic.2025.101238}
}
EUVIMED